Navigation Links
One Million Boxes of Over-the-Counter Smoking Cessation Products Sold in January 2008
Date:2/4/2008

okers quit smoking. Data from more than 100 clinical trials among more than 35,000 people have established the safety and efficacy profile of therapeutic nicotine for successful smoking cessation. These products are available without a doctor's prescription, in flexible dosing options at more than 35,000 retail outlets across the country.

"We are thrilled to see so many people trying to get their new year started in a healthy way by quitting smoking. But we know for some people, this is not an easy addiction to break, and we want to remind them of the safe options to wean them off of nicotine -- like NicoDerm CQ -- which are easily available to help support their quit attempts," said Bill Slivka, Vice President Smoking Control, GlaxoSmithKline Consumer Healthcare.

To encourage people to quit smoking for the rest of 2008, GSK Consumer Healthcare is offering a free NicoDerm CQ placebo patch or a 20-count box of Nicorette Cinnamon Surge to consumers. The placebo patch is available online at http://www.NicodermCQ.com. It is intended to show smokers that the NicoDerm CQ patch is easy to use, comfortable and discrete. Nicorette gum is available by calling 1-800-NICORETTE. These offers will help smokers decide whether NicoDerm CQ or Nicorette is the right option for their quit attempt.

Quitting smoking is the most important step smokers can take to improve their health -- and it's also one of the most difficult. By developing innovative new products and support systems to improve the quit experience, GSK Consumer Healthcare is working to inspire and enable every smoker to quit.

About NicoDerm CQ

NicoDerm CQ is the best-selling smoking cessation patch in history and has helped millions of smokers quit. It is also the number one doctor-recommended patch to quit smoking. When used as directed, NicoDerm CQ allows a smoker to gradually adjust to having less nicotine until eventually he does
'/>"/>

SOURCE GlaxoSmithKline Consumer Healthcare
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. R Baby Foundation Raises $2.5 Million in First Year
2. PEAK Surgical, Inc. Closes $21 Million Series C Financing
3. China Sky One Medical Raises $25 Million in Private Placement
4. MediPurpose Sells 500 Millionth Safety Lancet to IMCO Member MMS Medical
5. Michael J. Fox Foundation awards up to $3 million to industry teams
6. Pennsylvania Governor Rendell Announces $1.8 Million Investment to Add Nurses, Improve Nurse Education Grants Awarded to Recipients in 28 Counties
7. Matrixx Initiatives, Inc. Reports Fiscal 3rd Quarter Net Sales of $30.8 Million and Net Loss of ($0.07) Per Share
8. Examination by National Expert Shows Blue Cross Blue Shield of Michigans Social Mission Contributions Totaled at Least $391 Million in 2007
9. Delray Beach Mayor Commemorates Diagnostic Centers of America (DCA) $2 Million Purchase from Siemens to Become Only Medical Facility in South Florida with Worlds Most Advanced Cardiac Scanner.
10. Helios Education Foundation Invests $6.5 Million in New Partnership with TGen
11. The Highmark Foundation Awards $4 Million in Highmark Healthy High 5 Grants to Two Nonprofit Organizations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2014)... NV (PRWEB) September 21, 2014 ... method developed by fitness expert Michael Wren that has ... stubborn weight and reverse health conditions like high blood ... attention of Shane Michaels, prompting an investigative review. ... methods and tips upside down by showing people what ...
(Date:9/20/2014)... 2014 Villa del Palmar at the ... experience any damage in relation to Hurricane Odile and ... , Hurricane Odile struck Cabo San Lucas the night ... powerful surf conditions. Located on the east side of ... experienced some heavy rain, but no damage whatsoever to ...
(Date:9/20/2014)... 20, 2014 On Monday, September 22, ... pediatric cancer research grant from Hyundai Hope on Wheels ... Children’s Hospital located on 11234 Anderson St., in Loma ... Kimberley Payne, Associate Professor at Loma Linda University and ... leukemia in children. , Loma Linda University ...
(Date:9/20/2014)... Sept. 19, 2014 (HealthDay News) -- The avian flu ... 2011 could be spread through respiratory drops and therefore ... new study. Although no human illnesses have been ... Jude Children,s Research hospital have discovered natural mutations to ... to travel through the air in droplets. Current ...
(Date:9/20/2014)... New PharmaPoint Drug Evaluation report, “Symbicort ... The asthma market saw very slow growth over ... with relatively efficacious standard therapies, such as short-acting ... long-acting beta-agonists (ICS/LABAs), and leukotriene modifiers, and has ... launch of seven novel targeted biologic agents and ...
Breaking Medicine News(10 mins):Health News:Weight Destroyer: Review Exposes Michael Wren’s Guide to Effective Weight Loss and Improved Health 2Health News:Weight Destroyer: Review Exposes Michael Wren’s Guide to Effective Weight Loss and Improved Health 3Health News:Villa del Palmar at the Islands of Loreto Fully Functioning After Hurricane 2Health News:Villa del Palmar at the Islands of Loreto Fully Functioning After Hurricane 3Health News:Loma Linda University Medical Center Receives $250,000 Research Grant From Hyundai Hope On Wheels In Honor Of National Childhood Cancer Awareness Month 2Health News:Loma Linda University Medical Center Receives $250,000 Research Grant From Hyundai Hope On Wheels In Honor Of National Childhood Cancer Awareness Month 3Health News:Avian Flu In Harbor Seals Could Infect People 2Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 2Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 3Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 4
... Now Available at Sunrise Communities and Online -MCLEAN, Va. ... SRZ ) now offers a new informational guide to ... senior care in today,s challenging economy. The guide, ... is available at Sunrise communities nationwide and also online ...
... The American Dietetic Association will pursue a broad agenda ... Congress that a primary goal of new legislation should be ... should improve as a result of our health policy choices," ... needs to rise as a national priority, as it ties ...
... Enterprises to Capture and Automate Faxes to Enhance Productivity and Facilitate ... ... 2009 -- FaxBack® , the high-density VoIP fax leader for ... Machine Integration Server , an easy-to-install plug-in that turns fax machines ...
... rank low as risk factor, study finds , , MONDAY, ... not a predictor of future violent behavior, but mental ... the risk, according to U.S. researchers who analyzed data ... a severe mental illness but no substance abuse or ...
... drug vigabatrin (VGB) has been shown to be one of ... infants, called infantile spasm. However, its use has been limited ... a permanent narrowing of visual fields in approximately 40 percent ... later. A new study published in Epilepsia examined ...
... COLUMBUS, Ga., Feb. 2 Aflac Incorporated today,reported its fourth ... from the strengthening of the yen to the dollar,in the ... billion,in the fourth quarter of 2007. Net earnings were ... or $.78 per share, a year ago. , ...
Cached Medicine News:Health News:Sunrise Senior Living Helps Families Explore Senior Care Financing Options with New Guide 2Health News:American Dietetic Association Announces Agenda for Health Reform 2Health News:FaxBack Enables Fax Machine Integration With Document Management Systems 2Health News:FaxBack Enables Fax Machine Integration With Document Management Systems 3Health News:Mental Illness Doesn't Predict Violent Behavior 2Health News:Controversial medication may decrease spasms for infants with epilepsy 2Health News:Aflac Incorporated Announces Fourth Quarter Results, Sees 2008 RBC Ratio Above 450%, Affirms 2009 Operating EPS Target 2Health News:Aflac Incorporated Announces Fourth Quarter Results, Sees 2008 RBC Ratio Above 450%, Affirms 2009 Operating EPS Target 3Health News:Aflac Incorporated Announces Fourth Quarter Results, Sees 2008 RBC Ratio Above 450%, Affirms 2009 Operating EPS Target 4Health News:Aflac Incorporated Announces Fourth Quarter Results, Sees 2008 RBC Ratio Above 450%, Affirms 2009 Operating EPS Target 5Health News:Aflac Incorporated Announces Fourth Quarter Results, Sees 2008 RBC Ratio Above 450%, Affirms 2009 Operating EPS Target 6Health News:Aflac Incorporated Announces Fourth Quarter Results, Sees 2008 RBC Ratio Above 450%, Affirms 2009 Operating EPS Target 7Health News:Aflac Incorporated Announces Fourth Quarter Results, Sees 2008 RBC Ratio Above 450%, Affirms 2009 Operating EPS Target 8Health News:Aflac Incorporated Announces Fourth Quarter Results, Sees 2008 RBC Ratio Above 450%, Affirms 2009 Operating EPS Target 9Health News:Aflac Incorporated Announces Fourth Quarter Results, Sees 2008 RBC Ratio Above 450%, Affirms 2009 Operating EPS Target 10Health News:Aflac Incorporated Announces Fourth Quarter Results, Sees 2008 RBC Ratio Above 450%, Affirms 2009 Operating EPS Target 11Health News:Aflac Incorporated Announces Fourth Quarter Results, Sees 2008 RBC Ratio Above 450%, Affirms 2009 Operating EPS Target 12Health News:Aflac Incorporated Announces Fourth Quarter Results, Sees 2008 RBC Ratio Above 450%, Affirms 2009 Operating EPS Target 13Health News:Aflac Incorporated Announces Fourth Quarter Results, Sees 2008 RBC Ratio Above 450%, Affirms 2009 Operating EPS Target 14Health News:Aflac Incorporated Announces Fourth Quarter Results, Sees 2008 RBC Ratio Above 450%, Affirms 2009 Operating EPS Target 15
(Date:9/19/2014)... , Sept. 19, 2014  Today DePuy ... new variable angle plating systems featuring its proprietary ... can adapt screw trajectory to match patient anatomy ... fragments of bone. The systems are being introduced ... Ankle Society (AOFAS) and the International Federation of ...
(Date:9/19/2014)... , Sept. 19, 2014 /PRNewswire-iReach/ -- ... to 2020″, provides key market data ... devices market. The report provides value, ... volume (in units) within market categories ... Sigmoidoscopes, Esophagoscopes & Gastroscopes, Duodenoscopes, Laparoscopes, ...
(Date:9/19/2014)... TRIANGLE PARK, N.C. , Sept. 19, 2014 ... focused on cloud-based drug design and development, partnering ... The company,s mission is to design new drugs ... 1 and 2 partners to further their development. ... its portfolio investments. To support this business model, ...
Breaking Medicine Technology:DePuy Synthes Proprietary Variable Angle Locking Technology Now Available To Treat Calcaneal Fractures And Medial Column Fusion Procedures 2DePuy Synthes Proprietary Variable Angle Locking Technology Now Available To Treat Calcaneal Fractures And Medial Column Fusion Procedures 3United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 2United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 3United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 4United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 5Cloud Pharmaceuticals Announces Partnering Sessions and Presentation Schedule 2
... C onsiderably higher risk of follicular lymphoma-related death in ... waxing and waning progression of disease , , ... ( NCCC ) recently ... lymphoma in California. , , Although survival rates ...
... , , , CAPE TOWN, ... today at the 5(th) International AIDS Society Conference from ARTEN ( ... and E mtricitabine [Truvada(R)] versus N evirapine). ARTEN is ... the first large study to directly compare the efficacy and safety ...
Cached Medicine Technology:Northern California Cancer Center's First-of-Its-Kind Research Reveals Low Socioeconomic Status Often Equals Poor Chance of Lymphoma Survival 2New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine (TDF/FTC) Versus Boosted Protease Inhibitor Regimen of Atazanavir/Ritonavir Plus TDF/FTC Revealed 2New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine (TDF/FTC) Versus Boosted Protease Inhibitor Regimen of Atazanavir/Ritonavir Plus TDF/FTC Revealed 3New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine (TDF/FTC) Versus Boosted Protease Inhibitor Regimen of Atazanavir/Ritonavir Plus TDF/FTC Revealed 4New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine (TDF/FTC) Versus Boosted Protease Inhibitor Regimen of Atazanavir/Ritonavir Plus TDF/FTC Revealed 5New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine (TDF/FTC) Versus Boosted Protease Inhibitor Regimen of Atazanavir/Ritonavir Plus TDF/FTC Revealed 6
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: